| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/03/2009 | US20090221703 High penetration composition and uses thereof |
| 09/03/2009 | US20090221697 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221653 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3H)-one-derivatives as beta2 adrenoreceptor agonists |
| 09/03/2009 | US20090221641 Diaza-spiro--nonane derivatives as neurokinin (nk1) antagonists |
| 09/03/2009 | US20090221640 Novel Crystal Modifications |
| 09/03/2009 | US20090221635 Quinolinyl and benzothiazolyl modulators |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221600 Pyrido-pyridimidine derivatives useful as antiinflammatory agents |
| 09/03/2009 | US20090221581 Methods of treating pain |
| 09/03/2009 | US20090221569 Use of lhrh antagonists for intermittent treatments |
| 09/03/2009 | US20090221567 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | US20090221548 Melanin concentrating hormone receptor-1 antagonists |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221542 Inhibition of Inflammatory Cytokine Production With Tanshinones |
| 09/03/2009 | US20090221517 Biologically Active Compounds |
| 09/03/2009 | US20090221506 Gdnf derived peptides |
| 09/03/2009 | US20090221469 Use of soy kefir powder for reducing pain, blood pressure and inflammation |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090220583 Method and composition for treating inflammatory disorders |
| 09/03/2009 | US20090220519 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 09/03/2009 | US20090220464 Mesenchymal stem cells and uses therefor |
| 09/03/2009 | CA2716755A1 Protein kinase modulators |
| 09/03/2009 | CA2716613A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | CA2716476A1 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2716223A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2714573A1 Indazole derivatives |
| 09/03/2009 | CA2713718A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2713710A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2713324A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2712507A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
| 09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2095817A1 Therapeutic compositions and methods |
| 09/02/2009 | EP2094709A1 Thiazole pyrazolopyrimidines as crf1 receptor antagonists |
| 09/02/2009 | EP2094707A1 Heterobicyclic matrix metalloprotease inhibitors |
| 09/02/2009 | EP2094701A2 Compounds and methods for kinase modulation, and indications therefor |
| 09/02/2009 | EP2094698A1 Substituted 6-phenyl-pyrido [2,3-d]pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 09/02/2009 | EP2094697A1 5-sulfanylmethyl-pyrazolo [1,5-a]pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 09/02/2009 | EP2094696A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 09/02/2009 | EP2094692A2 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094688A1 Heterocyclic compounds with cxcr3 antagonist activity |
| 09/02/2009 | EP2094682A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 09/02/2009 | EP2094671A1 Heterobicyclic metalloprotease inhibitors |
| 09/02/2009 | EP2094653A1 O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists |
| 09/02/2009 | EP2094646A1 Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases |
| 09/02/2009 | EP2094640A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar). |
| 09/02/2009 | EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1478365B1 Combination consisting of trapidil and 5ht2-serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
| 09/02/2009 | EP1326584B1 Delivery system and method of treating or preventing otitis media |
| 09/02/2009 | CN101519393A Novel method for preparing Scopoletin |
| 09/02/2009 | CN101518666A Medicament heat physical therapy belt for waists, legs and necks |
| 09/02/2009 | CN101518655A Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament |
| 09/02/2009 | CN101518654A Method for synthesizing novel preparation capable of carrying glucocorticoid to be used as inflammation targeted drug |
| 09/02/2009 | CN101518649A Compound preparation for treating ophthalmic infection and inflammation |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518643A Antiphlogistic and analgesic ointment |
| 09/02/2009 | CN101518631A Medicament for treating rheumatoid arthritis |
| 09/02/2009 | CN101518626A Medicine for treating rheumatism by hot application method |
| 09/02/2009 | CN101518599A Slow-release patch with daphne giraldii bark extract, and preparation method thereof |
| 09/02/2009 | CN101518592A Granule used for treating cold due to wind-heat and preparation method thereof |
| 09/02/2009 | CN101518588A Traditional Chinese medicine for treating diabetic arthrodynia |
| 09/02/2009 | CN101518573A External pulvis for treating rheumatoid arthritis |
| 09/02/2009 | CN101518564A Application of the effective part of astragalus hoangtchy in preparation of anti-inflammatory |
| 09/02/2009 | CN101518560A Application of thladiantha dubia bunge root extract to preparation of anti-inflammatory drugs or/and analgesics |
| 09/02/2009 | CN101518559A Chinese medicinal preparation for treating bone disease |
| 09/02/2009 | CN101518531A Analgesic anti-inflammatory composite medicament and method for preparing same |
| 09/02/2009 | CN101518526A Drug combination |
| 09/02/2009 | CN101518521A New medical application of cedrol |
| 09/02/2009 | CN101518520A Framework-type transdermal patch with dextro ketoprofen accumulated in subcutaneous deep tissues |
| 09/02/2009 | CN101518353A Alcohol-detoxication inflammation-relieving liver-protection beverage and preparation method thereof |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 09/02/2009 | CN100534530C Vehicle for topical delivery of anti-inflammatory compounds |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582661 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; 2-Amino-5-chloro-phenyl)-(3-methyl-pyridin-4-yl)-methanone |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2448689C Percutaneously absorbable patches |